{"id":3131,"date":"2009-01-14T12:21:11","date_gmt":"2009-01-14T12:21:11","guid":{"rendered":"https:\/\/www.cornerstone.com\/?post_type=case_study&#038;p=3131"},"modified":"2022-06-27T11:36:39","modified_gmt":"2022-06-27T16:36:39","slug":"misleading-statements-regarding-drug-safety","status":"publish","type":"case_study","link":"https:\/\/www.cornerstone.com\/insights\/cases\/misleading-statements-regarding-drug-safety\/","title":{"rendered":"Misleading Statements regarding Drug Safety"},"content":{"rendered":"","protected":false},"featured_media":0,"template":"","categories":[60],"tags":[25],"asset_type":[79],"class_list":["post-3131","case_study","type-case_study","status-publish","hentry","category-securities-litigation","tag-europe"],"acf":[],"yoast_head":"\n<title>Misleading Statements regarding Drug Safety | Cornerstone Research<\/title>\n<meta name=\"description\" content=\"In this Rule 10b-5 case, the plaintiffs alleged that the price of ordinary common shares of a major pharmaceutical company, primarily traded in Europe, and American Depository Receipts (ADRs), traded in the United States, were artificially inflated due to false and misleading statements made by the company regarding the safety of a specific drug.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cornerstone.com\/insights\/cases\/misleading-statements-regarding-drug-safety\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Misleading Statements regarding Drug Safety\" \/>\n<meta property=\"og:description\" content=\"In this Rule 10b-5 case, the plaintiffs alleged that the price of ordinary common shares of a major pharmaceutical company, primarily traded in Europe, and American Depository Receipts (ADRs), traded in the United States, were artificially inflated due to false and misleading statements made by the company regarding the safety of a specific drug.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cornerstone.com\/insights\/cases\/misleading-statements-regarding-drug-safety\/\" \/>\n<meta property=\"og:site_name\" content=\"Cornerstone Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/CornerstoneResearchInc\" \/>\n<meta property=\"article:modified_time\" content=\"2022-06-27T16:36:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cornerstone.com\/wp-content\/uploads\/2022\/01\/greenlogo.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"300\" \/>\n\t<meta property=\"og:image:height\" content=\"210\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@Cornerstone_Res\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cornerstone.com\/insights\/cases\/misleading-statements-regarding-drug-safety\/\",\"url\":\"https:\/\/www.cornerstone.com\/insights\/cases\/misleading-statements-regarding-drug-safety\/\",\"name\":\"Misleading Statements regarding Drug Safety | Cornerstone Research\",\"isPartOf\":{\"@id\":\"https:\/\/www.cornerstone.com\/#website\"},\"datePublished\":\"2009-01-14T12:21:11+00:00\",\"dateModified\":\"2022-06-27T16:36:39+00:00\",\"description\":\"In this Rule 10b-5 case, the plaintiffs alleged that the price of ordinary common shares of a major pharmaceutical company, primarily traded in Europe, and American Depository Receipts (ADRs), traded in the United States, were artificially inflated due to false and misleading statements made by the company regarding the safety of a specific drug.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cornerstone.com\/insights\/cases\/misleading-statements-regarding-drug-safety\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cornerstone.com\/insights\/cases\/misleading-statements-regarding-drug-safety\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cornerstone.com\/insights\/cases\/misleading-statements-regarding-drug-safety\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cornerstone.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Misleading Statements regarding Drug Safety\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cornerstone.com\/#website\",\"url\":\"https:\/\/www.cornerstone.com\/\",\"name\":\"Cornerstone Research\",\"description\":\"Economic and Financial Consulting and Expert Testimony\",\"publisher\":{\"@id\":\"https:\/\/www.cornerstone.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cornerstone.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cornerstone.com\/#organization\",\"name\":\"Cornerstone Research\",\"url\":\"https:\/\/www.cornerstone.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.cornerstone.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cornerstone.com\/wp-content\/uploads\/2022\/01\/Cornerstone-Research-Logo.jpg\",\"contentUrl\":\"https:\/\/www.cornerstone.com\/wp-content\/uploads\/2022\/01\/Cornerstone-Research-Logo.jpg\",\"width\":1000,\"height\":61,\"caption\":\"Cornerstone Research\"},\"image\":{\"@id\":\"https:\/\/www.cornerstone.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/CornerstoneResearchInc\",\"https:\/\/x.com\/Cornerstone_Res\",\"https:\/\/www.linkedin.com\/company\/cornerstone-research\/\"]}]}<\/script>\n","yoast_head_json":{"title":"Misleading Statements regarding Drug Safety | Cornerstone Research","description":"In this Rule 10b-5 case, the plaintiffs alleged that the price of ordinary common shares of a major pharmaceutical company, primarily traded in Europe, and American Depository Receipts (ADRs), traded in the United States, were artificially inflated due to false and misleading statements made by the company regarding the safety of a specific drug.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cornerstone.com\/insights\/cases\/misleading-statements-regarding-drug-safety\/","og_locale":"en_US","og_type":"article","og_title":"Misleading Statements regarding Drug Safety","og_description":"In this Rule 10b-5 case, the plaintiffs alleged that the price of ordinary common shares of a major pharmaceutical company, primarily traded in Europe, and American Depository Receipts (ADRs), traded in the United States, were artificially inflated due to false and misleading statements made by the company regarding the safety of a specific drug.","og_url":"https:\/\/www.cornerstone.com\/insights\/cases\/misleading-statements-regarding-drug-safety\/","og_site_name":"Cornerstone Research","article_publisher":"https:\/\/www.facebook.com\/CornerstoneResearchInc","article_modified_time":"2022-06-27T16:36:39+00:00","og_image":[{"width":300,"height":210,"url":"https:\/\/www.cornerstone.com\/wp-content\/uploads\/2022\/01\/greenlogo.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@Cornerstone_Res","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cornerstone.com\/insights\/cases\/misleading-statements-regarding-drug-safety\/","url":"https:\/\/www.cornerstone.com\/insights\/cases\/misleading-statements-regarding-drug-safety\/","name":"Misleading Statements regarding Drug Safety | Cornerstone Research","isPartOf":{"@id":"https:\/\/www.cornerstone.com\/#website"},"datePublished":"2009-01-14T12:21:11+00:00","dateModified":"2022-06-27T16:36:39+00:00","description":"In this Rule 10b-5 case, the plaintiffs alleged that the price of ordinary common shares of a major pharmaceutical company, primarily traded in Europe, and American Depository Receipts (ADRs), traded in the United States, were artificially inflated due to false and misleading statements made by the company regarding the safety of a specific drug.","breadcrumb":{"@id":"https:\/\/www.cornerstone.com\/insights\/cases\/misleading-statements-regarding-drug-safety\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cornerstone.com\/insights\/cases\/misleading-statements-regarding-drug-safety\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.cornerstone.com\/insights\/cases\/misleading-statements-regarding-drug-safety\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cornerstone.com\/"},{"@type":"ListItem","position":2,"name":"Misleading Statements regarding Drug Safety"}]},{"@type":"WebSite","@id":"https:\/\/www.cornerstone.com\/#website","url":"https:\/\/www.cornerstone.com\/","name":"Cornerstone Research","description":"Economic and Financial Consulting and Expert Testimony","publisher":{"@id":"https:\/\/www.cornerstone.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cornerstone.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.cornerstone.com\/#organization","name":"Cornerstone Research","url":"https:\/\/www.cornerstone.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.cornerstone.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.cornerstone.com\/wp-content\/uploads\/2022\/01\/Cornerstone-Research-Logo.jpg","contentUrl":"https:\/\/www.cornerstone.com\/wp-content\/uploads\/2022\/01\/Cornerstone-Research-Logo.jpg","width":1000,"height":61,"caption":"Cornerstone Research"},"image":{"@id":"https:\/\/www.cornerstone.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/CornerstoneResearchInc","https:\/\/x.com\/Cornerstone_Res","https:\/\/www.linkedin.com\/company\/cornerstone-research\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.cornerstone.com\/wp-json\/wp\/v2\/case_study\/3131"}],"collection":[{"href":"https:\/\/www.cornerstone.com\/wp-json\/wp\/v2\/case_study"}],"about":[{"href":"https:\/\/www.cornerstone.com\/wp-json\/wp\/v2\/types\/case_study"}],"version-history":[{"count":1,"href":"https:\/\/www.cornerstone.com\/wp-json\/wp\/v2\/case_study\/3131\/revisions"}],"predecessor-version":[{"id":12859,"href":"https:\/\/www.cornerstone.com\/wp-json\/wp\/v2\/case_study\/3131\/revisions\/12859"}],"wp:attachment":[{"href":"https:\/\/www.cornerstone.com\/wp-json\/wp\/v2\/media?parent=3131"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cornerstone.com\/wp-json\/wp\/v2\/categories?post=3131"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cornerstone.com\/wp-json\/wp\/v2\/tags?post=3131"},{"taxonomy":"asset_type","embeddable":true,"href":"https:\/\/www.cornerstone.com\/wp-json\/wp\/v2\/asset_type?post=3131"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}